Antibody drug conjugates for the treatment of multiple myeloma.

Leong, Sarah; Lam, Ho Pui Jeff; Kirkham, Zoe; Popat, Rakesh

Leong, Sarah; Lam, Ho Pui Jeff; Kirkham, Zoe; Popat, Rakesh.

Afiliação

Leong S; National Institute for Health Research University College London Hospitals Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK.
Lam HPJ; National Institute for Health Research University College London Hospitals Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK.
Kirkham Z; National Institute for Health Research University College London Hospitals Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK.
Popat R; National Institute for Health Research University College London Hospitals Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK.

Am J Hematol ; 98 Suppl 2: S22-S34, 2023 03.

Article em En | MEDLINE | ID: mdl-36199262

Assuntos

Imunoconjugados; Mieloma Múltiplo; Humanos; Mieloma Múltiplo/tratamento farmacológico; Imunoconjugados/efeitos adversos; Imunoterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google